Header Logo

Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.

Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA. 2022 07 12; 328(2):213-214.

View in: PubMed